Chronic Disease Progression Records
This dataset provides comprehensive, time-stamped records of chronic disease progression for individual patients, including clinical measurements, symptom severity, treatment details, and adverse events. It enables longitudinal analysis of disease outcomes and treatment effectiveness, supporting research, clinical decision-making, and population health studies.
Sample rows
preview · 8 of 200 rows · all 15 columns| record_idstring | disease_stagestring | symptom_severity_scorefloat | disease_codestring | patient_idstring | disease_namestring | progression_datedate | clinical_measurementsstring | treatment_typestring | treatment_namestring | treatment_start_datedate | treatment_end_datedate | adverse_eventsstring | next_followup_datedate | notesstring |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REC0001 | mild | 1.2 | E11.9 | PAT1001 | Type 2 Diabetes Mellitus | 2020-01-14 | HbA1c: 6.1%, FPG: 110 mg/dL, BP: 126/82 | lifestyle_modification | Diet control, walking | 2020-01-14 | blank | blank | 2020-07-14 | Patient displays mild symptoms with stable glucose levels. |
| REC0002 | moderate | 4.3 | I10 | PAT1002 | Essential Hypertension | 2020-02-18 | BP: 148/92, HR: 74 bpm | medication | Lisinopril 10mg | 2020-02-18 | blank | Dizziness: mild | 2020-05-18 | Blood pressure moderately elevated; medication started. |
| REC0003 | stable | 0.7 | J45.909 | PAT1003 | Asthma, Unspecified | 2020-03-07 | FEV1: 85%, O2 Sat: 98% | medication | Albuterol inhaler | 2020-03-07 | blank | blank | 2020-09-07 | Asthma well controlled, no exacerbations reported. |
| REC0004 | severe | 9.1 | C34.1 | PAT1004 | Malignant Neoplasm of Upper Lobe, Right Bronchus or Lung | 2020-04-12 | CT: 4.2 cm mass, SpO2: 89% | chemotherapy | Cisplatin, etoposide | 2020-04-12 | 2020-06-15 | Nausea: severe, Fatigue: moderate | 2020-06-27 | Lung mass increased, patient started chemotherapy. |
| REC0005 | mild | 1 | E78.0 | PAT1005 | Pure Hypercholesterolemia | 2020-05-21 | Total Cholesterol: 242 mg/dL, LDL: 158 mg/dL | medication | Atorvastatin 20mg | 2020-05-21 | blank | blank | 2020-11-21 | Statin therapy initiated for mild hypercholesterolemia. |
| REC0006 | progressing | 6.9 | G35 | PAT1006 | Multiple Sclerosis | 2020-06-12 | EDSS: 4.5, MRI: new lesions | biologic | Ocrelizumab infusion | 2020-06-12 | blank | Infusion reaction: mild | 2020-09-12 | MS progression with new MRI findings; biologic started. |
| REC0007 | severe | 9.8 | I50.9 | PAT1007 | Heart Failure, Unspecified | 2020-07-18 | EF: 18%, BNP: 745 pg/mL | medication | Carvedilol, Furosemide | 2020-07-18 | blank | Orthostatic hypotension: moderate | 2020-08-18 | Worsening heart failure, reduced EF, symptoms severe. |
| REC0008 | progressing | 5.6 | E11.9 | PAT1001 | Type 2 Diabetes Mellitus | 2020-08-17 | HbA1c: 7.8%, FPG: 142 mg/dL | medication | Metformin, glipizide | 2020-08-17 | blank | Hypoglycemia: mild | 2020-10-17 | Glucose control worsening; combination therapy started. |
| REC0009 | severe | 8.7 | K74.60 | PAT1008 | Unspecified Cirrhosis of Liver | 2020-09-23 | ALT: 62 IU/L, AST: 80 IU/L, INR: 1.5 | medication | Spironolactone, Furosemide | 2020-09-23 | blank | Muscle cramps: moderate | 2020-10-23 | Cirrhosis advanced, ascites present, medication adjusted. |
| REC0010 | moderate | 5.3 | M05.79 | PAT1009 | Rheumatoid Arthritis, Multiple Sites | 2020-10-04 | CRP: 32 mg/L, ESR: 40 mm/hr | biologic | Adalimumab 40mg | 2020-10-04 | blank | Injection site pain: mild | 2020-12-04 | RA flaring; inflammatory markers high, biologic started. |
| REC0011 | remission | 0.4 | E11.9 | PAT1010 | Type 2 Diabetes Mellitus | 2020-11-10 | HbA1c: 5.8%, FPG: 99 mg/dL | none | blank | blank | blank | blank | 2021-05-10 | Diabetes in remission after weight loss. |
| REC0012 | progressing | 6.7 | J45.909 | PAT1011 | Asthma, Unspecified | 2020-12-19 | FEV1: 62%, Peak Flow: 310 L/min | medication | Fluticasone, Salmeterol | 2020-12-19 | blank | Oral thrush: mild | 2021-02-19 | Asthma worsening, step-up therapy needed. |
| REC0013 | stable | 0.8 | E78.0 | PAT1012 | Pure Hypercholesterolemia | 2021-01-29 | Total Cholesterol: 206 mg/dL, LDL: 132 mg/dL | lifestyle_modification | Low fat diet, exercise | 2021-01-29 | blank | blank | 2021-07-29 | Cholesterol controlled with lifestyle changes. |
| REC0014 | severe | 8.3 | I10 | PAT1013 | Essential Hypertension | 2021-02-16 | BP: 168/104, HR: 88 bpm | procedure | Renal denervation | 2021-02-18 | 2021-02-20 | Transient hypotension: moderate | 2021-03-20 | Hypertension refractory; procedure performed. |
| REC0015 | progressing | 7.2 | C34.1 | PAT1014 | Malignant Neoplasm of Upper Lobe, Right Bronchus or Lung | 2021-03-25 | CT: 3.5 cm mass, SpO2: 91% | procedure | Bronchoscopy with biopsy | 2021-03-25 | 2021-03-26 | Bleeding: mild | 2021-04-26 | Tumor increasing in size; biopsy performed. |
| REC0016 | moderate | 4.8 | E11.9 | PAT1015 | Type 2 Diabetes Mellitus | 2021-04-08 | HbA1c: 7.0%, FPG: 130 mg/dL | medication | Metformin 1000mg | 2021-04-08 | blank | GI upset: mild | 2021-06-08 | Glucose moderately elevated; dose adjusted. |
| REC0017 | remission | 0.2 | J45.909 | PAT1016 | Asthma, Unspecified | 2021-05-19 | FEV1: 88%, O2 Sat: 99% | none | blank | blank | blank | blank | 2021-11-19 | Asthma symptoms resolved; no medication needed. |
| REC0018 | progressing | 7.5 | K74.60 | PAT1017 | Unspecified Cirrhosis of Liver | 2021-06-21 | ALT: 72 IU/L, AST: 96 IU/L, INR: 1.7 | dialysis | Paracentesis, hemodialysis | 2021-06-21 | 2021-06-22 | Hypotension: severe | 2021-07-22 | Decompensated cirrhosis; procedures performed. |
| REC0019 | stable | 2.1 | I50.9 | PAT1018 | Heart Failure, Unspecified | 2021-07-10 | EF: 34%, BNP: 285 pg/mL | medication | Lisinopril, metoprolol | 2021-07-10 | blank | blank | 2021-10-10 | Heart failure symptoms controlled with medication. |
| REC0020 | progressing | 6.2 | I10 | PAT1002 | Essential Hypertension | 2021-08-15 | BP: 160/98, HR: 82 bpm | medication | Amlodipine 10mg | 2021-08-15 | blank | Edema: mild | 2021-09-15 | Hypertension worsening; medication changed. |
What the 200 rows show
from the 200-row sampleSevere (disease stage) stands out: mean symptom_
- 5.1median symptom_
severity_ score - 8treatment types
Median 5.1, from 0.0 to 10.0.
- string 10
- float 1
- date 4
Columns
15 columns in three groups| column | type | description | example |
|---|---|---|---|
| Text 10 columns | |||
record_id | string | Unique identifier for each disease progression recordunique | REC0001 |
patient_id | string | Unique identifier for each patient | PAT1001 |
disease_code | string | Standardized code representing the chronic disease (e.g., ICD-10)9 codes | E11.9 |
disease_name | string | Name of the chronic disease | Type 2 Diabetes Mellitus |
disease_stage | string | Current stage or severity of the disease at the time of measurement6 values | mild |
clinical_measurements | string | Key-value pairs of relevant clinical measurements (e.g., blood pressure, lab results) at this time pointoptional | BP: 148/92, HR: 74 bpm |
treatment_type | string | Type of treatment administered at this time point8 types · optional | lifestyle_modification |
treatment_name | string | Specific name or description of the treatment (e.g., medication name, procedure)optional | Diet control, walking |
adverse_events | string | Key-value pairs or list of adverse events experienced during this periodoptional | Dizziness: mild |
notes | string | Additional clinician notes or observationsoptional | Patient displays mild sym… |
| Numbers 1 column | |||
symptom_severity_score | float | Numeric score representing overall symptom severity (e.g., 0-10 scale)0 to 10 · optional | 1.2 |
| Dates and times 4 columns | |||
progression_date | date | Date when the progression measurement was taken | 2020-01-14 |
treatment_start_date | date | Date when the current treatment beganoptional | 2020-01-14 |
treatment_end_date | date | Date when the current treatment ended (if applicable)optional | 2020-06-15 |
next_followup_date | date | Scheduled date for the next follow-up appointmentoptional | 2020-07-14 |
Use it for
A healthcare dashboard
Symptom_
severity_ score by disease_ stage and a breakdown of disease_ code. Excel, Power BI or Tableau. Why do the 40 severe rows have a mean symptom_
severity_ score of 9.4? A root-cause class exercise
Hand out the rows and one question. The answer is in the data, not in the brief.
- Records200REC00011.2mildREC00024.3moderateREC00030.7stable
A software demo
Believable records with patient_
id, disease_ code and disease_ name to fill a screen in front of a buyer.
This dataset200 rows15 columns
Yours1,000 rows15 columns
blueprint · chronic-disease-progression-records
Behind this dataset
Same schema. As many rows as you need.
These 200 rows came out of a blueprint — 15 columns with generation rules behind each one. Open it in Data Factory to retune a column, add your own, wire in foreign keys, and run it at the size you actually need.
Rules it was built with
- Patient demographics and diagnosis
- Regular health metrics tracked
- Treatment regimen changes annotated
- Progression milestones recorded
Open the blueprint in Data Factory
1 credit per row. New accounts start with 25 free credits.
- Exports
- CSV, JSON, JSONL, Parquet, SQL, Excel, TSV, XML
- Licence
- yours to use, including commercially
- API slug
- chronic-disease-progression-records